CSN Login
Members Online: 6

You are here

Livatag(R) shows significant survival increase in advanced hepatocellular carcinoma patients

er_sandeep
Posts: 5
Joined: Feb 2011

Read this article today about Livatg which says that it extends survival benefits to 32 month in comparison of current 17 months.

Can some one suggest about it.

http://www.businesswire.com/news/home/20110627006456/en/BioAlliance-Pharma-Submits-Phase-III-Clinical-Trial

Subscribe to Comments for "Livatag(R) shows significant survival increase in advanced hepatocellular carcinoma patients"